Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Esophageal Neoplasms × Ferrosoferric Oxide × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thyroid Cancer, Papillary 1 Sarcoma 1 Pancreatic carcinoma, familial 1 Pancreatic Intraductal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Medullary 1 Cancer of Lymph Node 1 Brain Neoplasms 1 Adult Brain Glioblastoma 1

Interventions

Esophagectomy 9 Radiotherapy 7 Endoscopic Mucosal Resection 7 Enteral Nutrition 6 Endoscopy 6 Standard of Care 5 Magnetic Resonance Spectroscopy 5 Fluorouracil 5 Exercise 5 Cisplatin 5 Surveys and Questionnaires 4 camrelizumab 3 Radiofrequency Ablation 3 Preoperative Exercise 3 Fluorodeoxyglucose F18 3 Blood Specimen Collection 3 spartalizumab 2 Yoga 2 X-Rays 2 Robotic Surgical Procedures 2 Psychosocial Intervention 2 Proton Therapy 2 Practice Guidelines as Topic 2 Palliative Care 2 Paclitaxel 2 Oxaliplatin 2 Octreotide 2 Nutrition Assessment 2 Neoadjuvant Therapy 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02253602 2019-01-16

IMPROVE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡